NCT00010400View on ClinicalTrials.gov

Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 1997

Conditions
Systemic Lupus ErythematosusAntiphospholipid Antibody Syndrome
Interventions
DRUG

Cyclophosphamide

DRUG

filgrastim

Trial Locations (2)

21205

Johns Hopkins University School of Medicine, Baltimore

21231

Johns Hopkins Oncology Center, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER